246 related articles for article (PubMed ID: 30024955)
1. Urine proteome analysis by C18 plate-matrix-assisted laser desorption/ionization time-of-flight mass spectrometry allows noninvasive differential diagnosis and prediction of diabetic nephropathy.
Chen CJ; Liao WL; Chang CT; Liao HY; Tsai FJ
PLoS One; 2018; 13(7):e0200945. PubMed ID: 30024955
[TBL] [Abstract][Full Text] [Related]
2. Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients.
Dihazi H; Müller GA; Lindner S; Meyer M; Asif AR; Oellerich M; Strutz F
Clin Chem; 2007 Sep; 53(9):1636-45. PubMed ID: 17634209
[TBL] [Abstract][Full Text] [Related]
3. Urine proteome analysis may allow noninvasive differential diagnosis of diabetic nephropathy.
Papale M; Di Paolo S; Magistroni R; Lamacchia O; Di Palma AM; De Mattia A; Rocchetti MT; Furci L; Pasquali S; De Cosmo S; Cignarelli M; Gesualdo L
Diabetes Care; 2010 Nov; 33(11):2409-15. PubMed ID: 20671095
[TBL] [Abstract][Full Text] [Related]
4. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
5. [Analyzing urinary proteome patterns of metabolic syndrome patients with early renal injury by magnet bead separation and matrix-assisted laser desorption ionization time-of-flight mass spectrometry].
Gao BX; Li MX; Liu XJ; Cai JF; Fan XH; Yang XL; Li XM; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):511-6. PubMed ID: 22338134
[TBL] [Abstract][Full Text] [Related]
6. 5-Hydroxyhexanoic Acid Predicts Early Renal Functional Decline in Type 2 Diabetes Patients with Microalbuminuria.
Tang X; You J; Liu D; Xia M; He L; Liu H
Kidney Blood Press Res; 2019; 44(2):245-263. PubMed ID: 31071709
[TBL] [Abstract][Full Text] [Related]
7. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
8. Urinary proteome analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with magnetic beads for identifying the pathologic presentation of clinical early IgA nephropathy.
He Q; Shao L; Yu J; Ji S; Wang H; Mao Y; Chen J
J Biomed Nanotechnol; 2012 Feb; 8(1):133-9. PubMed ID: 22515101
[TBL] [Abstract][Full Text] [Related]
9. The study of interferences for diagnosing albuminuria by matrix-assisted laser desorption ionization/time-of-flight mass spectrometry.
Cho YT; Chen YS; Hu JL; Shiea J; Yeh SM; Chen HC; Lee YC; Wu DC
Clin Chim Acta; 2012 May; 413(9-10):875-82. PubMed ID: 22327002
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder.
Jain S; Rajput A; Kumar Y; Uppuluri N; Arvind AS; Tatu U
J Assoc Physicians India; 2005 Jun; 53():513-20. PubMed ID: 16121805
[TBL] [Abstract][Full Text] [Related]
11. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.
Yang YH; Zhang S; Cui JF; Lu B; Dong XH; Song XY; Liu YK; Zhu XX; Hu RM
Diabet Med; 2007 Dec; 24(12):1386-92. PubMed ID: 18042080
[TBL] [Abstract][Full Text] [Related]
13. Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes.
Magagnotti C; Zerbini G; Fermo I; Carletti RM; Bonfanti R; Vallone F; Andolfo A
J Proteomics; 2019 Feb; 193():205-216. PubMed ID: 30366120
[TBL] [Abstract][Full Text] [Related]
14. Discovery and verification of urinary peptides in type 2 diabetes mellitus with kidney injury.
Fu G; Du Y; Chu L; Zhang M
Exp Biol Med (Maywood); 2016 Jun; 241(11):1186-94. PubMed ID: 26846977
[TBL] [Abstract][Full Text] [Related]
15. Stage-specific quantitative changes in renal and urinary proteome during the progression and development of streptozotocin-induced diabetic nephropathy in rats.
Sharma V; Tikoo K
Mol Cell Biochem; 2014 Mar; 388(1-2):95-111. PubMed ID: 24281856
[TBL] [Abstract][Full Text] [Related]
16. Finding diabetic nephropathy biomarkers in the plasma peptidome by high-throughput magnetic bead processing and MALDI-TOF-MS analysis.
Hansen HG; Overgaard J; Lajer M; Hubalek F; Højrup P; Pedersen L; Tarnow L; Rossing P; Pociot F; McGuire JN
Proteomics Clin Appl; 2010 Sep; 4(8-9):697-705. PubMed ID: 21137087
[TBL] [Abstract][Full Text] [Related]
17. Changes in urine proteome accompanying diabetic nephropathy progression.
Lewandowicz A; Bakun M; Kohutnicki R; Fabijańska A; Kistowski M; Imiela J; Dadlez M
Pol Arch Med Wewn; 2015; 125(1-2):27-38. PubMed ID: 25578432
[TBL] [Abstract][Full Text] [Related]
18. Urinary proteomics in diabetes and CKD.
Rossing K; Mischak H; Dakna M; Zürbig P; Novak J; Julian BA; Good DM; Coon JJ; Tarnow L; Rossing P;
J Am Soc Nephrol; 2008 Jul; 19(7):1283-90. PubMed ID: 18448586
[TBL] [Abstract][Full Text] [Related]
19. Identification of Urinary Metabolite Biomarkers of Type 2 Diabetes Nephropathy Using an Untargeted Metabolomic Approach.
Chen CJ; Liao WL; Chang CT; Lin YN; Tsai FJ
J Proteome Res; 2018 Nov; 17(11):3997-4007. PubMed ID: 30265543
[TBL] [Abstract][Full Text] [Related]
20. Increased urinary excretion of orosomucoid is a risk predictor of diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Liu H; Hou X; Cheng J
Nephrology (Carlton); 2009 Apr; 14(3):332-7. PubMed ID: 19143942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
